Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer

NJ Vogelzang; K Fizazi; JM Burke; Ronald de Wit; J Bellmunt; TE Hutson; E Crane; WR Berry; K Doner; JD Hainsworth; PJ Wiechno; KJ Liu; MF Waldman; A Gandhi; D Barton; U Jungnelius; A Fandi; CN Sternberg; DP Petrylak

doi:10.1016/j.eururo.2016.07.051

Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer

NJ Vogelzang, K Fizazi, JM Burke, Ronald de Wit, J Bellmunt, TE Hutson, E Crane, WR Berry, K Doner, JD Hainsworth, PJ Wiechno, KJ Liu, MF Waldman, A Gandhi, D Barton, U Jungnelius, A Fandi, CN Sternberg, DP Petrylak

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

53 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	168-171
Number of pages	4
Journal	European Urology
Volume	71
Issue number	2
DOIs	https://doi.org/10.1016/j.eururo.2016.07.051
Publication status	Published - 2017

Research programs

EMC MM-03-86-08

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eururo.2016.07.051

http://hdl.handle.net/1765/108250

Cite this

Vogelzang, NJ., Fizazi, K., Burke, JM., de Wit, R., Bellmunt, J., Hutson, TE., Crane, E., Berry, WR., Doner, K., Hainsworth, JD., Wiechno, PJ., Liu, KJ., Waldman, MF., Gandhi, A., Barton, D., Jungnelius, U., Fandi, A., Sternberg, CN., & Petrylak, DP. (2017). Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer. European Urology, 71(2), 168-171. https://doi.org/10.1016/j.eururo.2016.07.051

@article{d2c4ced3de954b5eb0e77da9a41a4dad,

title = "Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer",

author = "NJ Vogelzang and K Fizazi and JM Burke and {de Wit}, Ronald and J Bellmunt and TE Hutson and E Crane and WR Berry and K Doner and JD Hainsworth and PJ Wiechno and KJ Liu and MF Waldman and A Gandhi and D Barton and U Jungnelius and A Fandi and CN Sternberg and DP Petrylak",

year = "2017",

doi = "10.1016/j.eururo.2016.07.051",

language = "Undefined/Unknown",

volume = "71",

pages = "168--171",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "2",

}

Vogelzang, NJ, Fizazi, K, Burke, JM, de Wit, R, Bellmunt, J, Hutson, TE, Crane, E, Berry, WR, Doner, K, Hainsworth, JD, Wiechno, PJ, Liu, KJ, Waldman, MF, Gandhi, A, Barton, D, Jungnelius, U, Fandi, A, Sternberg, CN & Petrylak, DP 2017, 'Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer', European Urology, vol. 71, no. 2, pp. 168-171. https://doi.org/10.1016/j.eururo.2016.07.051

TY - JOUR

T1 - Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer

AU - Vogelzang, NJ

AU - Fizazi, K

AU - Burke, JM

AU - de Wit, Ronald

AU - Bellmunt, J

AU - Hutson, TE

AU - Crane, E

AU - Berry, WR

AU - Doner, K

AU - Hainsworth, JD

AU - Wiechno, PJ

AU - Liu, KJ

AU - Waldman, MF

AU - Gandhi, A

AU - Barton, D

AU - Jungnelius, U

AU - Fandi, A

AU - Sternberg, CN

AU - Petrylak, DP

PY - 2017

Y1 - 2017

U2 - 10.1016/j.eururo.2016.07.051

DO - 10.1016/j.eururo.2016.07.051

M3 - Article

C2 - 27522164

SN - 0302-2838

VL - 71

SP - 168

EP - 171

JO - European Urology

JF - European Urology

IS - 2

ER -